| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $3,177,564 ) |
| | 2025 | 2025 | SYNTIS BIO INC | 135 MORRISSEY BLVD | BOSTON | MA | 02125-3310 | SUFFOLK | USA | R44DK141341 | Development of an Oral Pill to Mimic the Effects of Gastric Bypass Surgery | 002 | 2 | NIH | 7/2/2025 | $916,400 |
| | 2025 | 2025 | SYNTIS BIO INC | 135 MORRISSEY BLVD | BOSTON | MA | 02125-3310 | SUFFOLK | USA | R44DK138869 | Polymer Epithelial Lining for the Oral Delivery of Macromolecules | 004 | 2 | NIH | 5/28/2025 | $1,245,529 |
| | 2025 | 2025 | SYNTIS BIO INC | 135 MORRISSEY BLVD | BOSTON | MA | 02125-3310 | SUFFOLK | USA | R44DK143766 | Development of Once-daily Oral Treatment for Maple Syrup Urine Disease | 000 | 1 | NIH | 9/8/2025 | $343,635 |
| | 2025 | 2025 | SYNTIS BIO INC | 135 MORRISSEY BLVD | BOSTON | MA | 02125-3310 | SUFFOLK | USA | R44HD118842 | Development of an Oral Methionine-Gamma-Lyase Enzyme for the Treatment of Homocystinuria | 000 | 1 | NIH | 9/16/2025 | $347,016 |
| | 2025 | 2025 | SYNTIS BIO INC | 135 MORRISSEY BLVD | BOSTON | MA | 02125-3310 | SUFFOLK | USA | R44HD118842 | Development of an Oral Methionine-Gamma-Lyase Enzyme for the Treatment of Homocystinuria | 001 | 1 | NIH | 9/24/2025 | $0 |
| | 2025 | 2025 | SYNTIS BIO INC | 135 MORRISSEY BLVD | BOSTON | MA | 02125-3310 | SUFFOLK | USA | R44DK142244 | Oral Therapeutics Platform for Treating Inborn Errors of Amino Acid Metabolism | 000 | 1 | NIH | 7/23/2025 | $324,984 |
| | 2025 | 2024 | SYNTIS BIO INC | 135 MORRISSEY BLVD | BOSTON | MA | 02125-3310 | SUFFOLK | USA | R44DK138869 | Polymer Epithelial Lining for the Oral Delivery of Macromolecules | 000 | 1 | NIH | 10/28/2024 | $0 |
| | 2025 | 2024 | SYNTIS BIO INC | 135 MORRISSEY BLVD | BOSTON | MA | 02125-3310 | SUFFOLK | USA | R44DK138869 | Polymer Epithelial Lining for the Oral Delivery of Macromolecules | 002 | 1 | NIH | 12/20/2024 | $0 |
| | 2025 | 2024 | SYNTIS BIO INC | 135 MORRISSEY BLVD | BOSTON | MA | 02125-3310 | SUFFOLK | USA | R44DK138869 | Polymer Epithelial Lining for the Oral Delivery of Macromolecules | 001 | 1 | NIH | 11/6/2024 | $0 |
| | 2025 | 2024 | SYNTIS BIO INC | 135 MORRISSEY BLVD | BOSTON | MA | 02125-3310 | SUFFOLK | USA | R44DK138869 | Polymer Epithelial Lining for the Oral Delivery of Macromolecules | 003 | 1 | NIH | 5/8/2025 | $0 |
| | 2025 | 2024 | SYNTIS BIO INC | 135 MORRISSEY BLVD | BOSTON | MA | 02125-3310 | SUFFOLK | USA | R44DK141341 | Development of an Oral Pill to Mimic the Effects of Gastric Bypass Surgery | 000 | 1 | NIH | 10/18/2024 | $0 |
| | 2025 | 2024 | SYNTIS BIO INC | 135 MORRISSEY BLVD | BOSTON | MA | 02125-3310 | SUFFOLK | USA | R44DK141341 | Development of an Oral Pill to Mimic the Effects of Gastric Bypass Surgery | 001 | 1 | NIH | 12/4/2024 | $0 |
| | 2025 | 2024 | SYNTIS BIO INC | 135 MORRISSEY BLVD | BOSTON | MA | 02125-3310 | SUFFOLK | USA | R44DK141341 | Development of an Oral Pill to Mimic the Effects of Gastric Bypass Surgery | 003 | 1 | NIH | 9/17/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $671,947 ) |
| | 2024 | 2024 | SYNTIS BIO INC | 135 MORRISSEY BLVD | BOSTON | MA | 02125-3310 | SUFFOLK | USA | R44DK141341 | Development of an Oral Pill to Mimic the Effects of Gastric Bypass Surgery | 000 | 1 | NIH | 9/12/2024 | $322,787 |
| | 2024 | 2024 | SYNTIS BIO INC | 69 RICHMOND ST | DORCHESTER | MA | 02124-5729 | SUFFOLK | USA | R44DK138869 | Polymer Epithelial Lining for the Oral Delivery of Macromolecules | 000 | 1 | NIH | 4/24/2024 | $349,160 |
|
|
